Agarose isoelectric focusing showed that both A M F and DAP, in common with many other glycoproteins, separated as distinct, closely aligned bands. DAP had a mean PI of 5.12 with a range of 5.05-5.20 and AMF, in agreement with previous reports, a mean PI of 4.75 and a range 4.7-4.8.
After trauma all the purified proteins from serum and liver contained only AMF-like protein (Table I ). The presence of AMF in liver confirms this organ as a source of the protein, although blood lymphocytes may be implicated in its synthesis (Panrucker & Lorscheider 1984) .
On day I2 of pregnancy decidual tissue contained only the DAP-like protein. Neither protein was found in the maternal liver, and despite the presence of high concentrations in the decidua, only traces of DAP were found in maternal serum, most being in the AMF form (Table 1) . This serum protein may be synthesized by other maternal tissues (Panrucker & Lorscheider, 1984) Factors involved in the function of cyclic nucleotide phosphodiesterases are interesting because their malfunction will disturb cyclic AMP levels, which affect humoral and neural transmission. The enzymes nearly all require free bivalent metal ions, probably Mgz+ in uiuo, though Mn'+, Co?+ and some others can often substitute in r,itro. The Mg?+-independent high-K, (Londesborough & Suoranta, 1983) and Mg?+-dependent low-K, (Suoranta & Londesborough, 1984) enzymes from yeast contain zinc and can be inactivated by metal chelators and reactivated by specific bivalent metal ions such as Zn?+. Are the mammalian enzymes also metalloproteins, whose levels and properties might depend on the bivalent metal ion status of the animals and on losses and substitutions of metals during purification? The effects of metal chelators on two partially purified mammalian phosphodiesterases are described here.
Salt extracts of rat liver plasma membranes containing the peripheral phosphodiesterase were prepared as described by Marchmont et al. (1981) . The enzyme was progressively inactivated by the metal chelators 8-hydroxyquinoline and o-phenanthroline (but not by the nonchelating m-phenanthroline), and re-activated by Zn2+ or Mn?+, but not by Mg2+, Ca?+, Cd2+, Co?+, Cu?+ or Fez+ (Londesborough, 1984) .
Bovine heart calmodulin-dependent phosphodiesterase from Sigma Chemical Co. (sp. activity, 0.16 units/mg; calmodulin activation, 6. I-fold) was assayed (Suoranta & Londesborough, 1984) at 30°C and pH7.4 in 2 5 m~-Tris/HCl buffer containing 25 mM-imidazole/HCl, 2 . 5 m~-MgCI,, 2mg of albumin/ml, 100 units of calmodulin/ml 40 ~M -C~C I
? and 50 pM-cyclic [ HJA M P. 0-Phenant hroline and 8-hydroxyquinoline caused progressive inactivations in buffer A [2.5mg of albumin/ml of 3 5 m~-P i p e s (l,4-piperazinediethanesulphonic a c i d ) / K o H / 2 5 p~-E D T A / 1 m~-2-mercaptoethanol, pH 7.0) that were not reversed by dialysis against buffer B (20m~-Tris/HCI/ 1 mM-imidazole/ 1 mM-MgC1, /SO m~-N a C 1 / 7 m~-2-mercaptoethano~/50 pM-EDTA, pH7.4) unless zinc acetate was included (Fig. I) . Addition of Zn?+ after the dialysis also caused re-activation, but Cd?+ and Mn?+ were much less effective. Untreated enzyme was unaffected by up to 100pM-Zn" in assays.
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contained also 280p~-zinc acetate.
calmodulin-dependent activities diminished at comparable rates (after 80% inactivation by o-phenanthroline or 8-hydroxyquinoline, respectively, calmodulin still activated by 6.6-or 4.4-fold). This evidence that the calmodulin-dependent phosphodiesterase contains essential metal, removed by hydrophobic chelators and replaced by specific metal salts, is weakened by the finding that the non-chelating m-and pphenanthrolines and 2-and 4-hydroxyquinolines, although less effective than the chelating isomers, caused some timedependent inactivation (Fig. I) . All four non-chelators are stronger instantaneous inhibitors than the chelating isomers (not shown) and possibly destabilize the enzyme by binding to a loosened conformation (perhaps co-ordinating to, but not chelating, a protein-bound metal). Addition of Zn2+ to assays potentiated 8-hydroxyquinoline-treated enzyme but inhibited 2-or 4-hydroxyquinoline-treated enzyme (Fig. I) . Furthermore, addition of 20nmol of CaClz and 200 units of calmodulin/ml to buffer A stabilized the enzyme in the absence of hydroxyquinolines or presence of 4-hydroxyquinoline, but labilized the enzyme in the presence of 8-hydroxyquinoline (for enzyme incubated with none, 2.2m~-4-hydroxyquinoline or 2.2 mM-8-hydroxyquinoline, respectively, inactivations in 5 h were 14%, 20% and 56% without Ca*+/calmodulin and 3%, 8% and 81% with Ca2+/ calmodulin), suggesting that calmodulin may expose a metal at the active site.
The significance of the probability that some mammalian phosphodiesterases are metallo(Zn?)-enzymes depends partly upon how sensitive the enzymes are in vivo to zinc deprivation. (BH,) functions as the essential cofactor for the phenylalanine hydroxylase-catalysed conversion of phenylalanine to tyrosine, the conversion of tryptophan to 5-hydroxytryptophan, catalysed by tryptophan hydroxylase, and for the rate-controlling enzyme of catecholamine synthesis, tyrosine hydroxylase, which converts tyrosine to dihydroxyphenylalanine. The cellular concentration of tetrahydrobiopterin is believed to determine the level of tyrosine hydroxylase activity (Kettler et al., 1974) and thus the rate of catecholamine synthesis.
5,6,7,8-Tetrahydrobiopterin
Abbreviation used: DHPR, dihydropteridine reductase.
Vol. 13 DHPR (EC 1.6.99.7) is responsible for the reconversion of the labile species quinonoid dihydrobiopterin, formed during the hydroxylation reactions, back into the active cofactor tetrahydrobiopterin. In conjunction with the pathway of tetrahydrobiopterin synthesis de novo, this salvage path catalysed by DHPR is important in maintaining the cellular concentrations of the enzyme cofactor. Tissues usually contain sufficient DHPR to maintain the cofactor in the fully reduced state (Craine et al., 1972) . Lead, a known neurotoxin, has in previous studies in vitro been implicated as an agent capable of altering the activity of DHPR in both rat brain and liver (Purdy et al., 1981) . In addition, studies in man have suggested an inhibitory effect of lead on the salvage pathway (McIntosh et al., 1980; Blair et al., 1982) . This study investigates the possible effect of lead on DHPR activity by using a rat model.
Male Sprague-Dawley rats were exposed to two concentrations of lead acetate (120 and 4 8 0~~) in their drinking water from weaning; a control group of rats received distilled water. Food and water were supplied ad libitum.
After a period of 4 or I2 weeks, the animals were killed by decapitation and the brains removed along with a sample of blood and a femur into lead free tubes. Freehand dissection
